Esquemas de tratamientos más utilizados parapacientes Covid-19 en UCI y emergencia del Hospital Teodoro Maldonado Carbo
Hurtado Monrroy and
Soledispa Cañarte
Health Leadership and Quality of Life, 2022, vol. 1, 88
Abstract:
This study will serve as the basis to guarantee optimal care for patients with Covid19 in critical areas of the Teodoro Maldonado Carbo Hospital in the City of Guayaquil. The objective was to analyze the therapeutic schemes used for the treatment of Covid-19 in hospitalized patients, by reviewing clinical records. The methodology was based on a retrospective cross-sectional study, in which 305 randomly selected clinical records of patients with a positive diagnosis were analyzed, with a degree of saturation below 90% from March 1 to May 31, 2020, The results determined that the most used therapeutic scheme was Scheme # 1 with 55.73% validated based on the deceased and discharged patients, the same one that was not the most effective, considering that 81.18% of the patients died. compared to the 18.82% who left discharged. The incidence of fatality in deceased patients was affected by the pre-existing diseases that the patients had, thus we have that of the 305 patients admitted, 82.95% had pre- existing diseases, of which 81% died. In conclusion, it is found that having pre-existing diseases considerably affects the deterioration of patients who contract Covid-19, so choosing the correct therapeutic scheme increases the possibility of success in the care of Covid19 patients.
Date: 2022
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:dbk:health:v:1:y:2022:i::p:88:id:88
DOI: 10.56294/hl202288
Access Statistics for this article
More articles in Health Leadership and Quality of Life from AG Editor
Bibliographic data for series maintained by Javier Gonzalez-Argote ().